ENGLEWOOD, Colo., June 12,
2019 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an
innovative medical technology company specializing in the
manufacture and sale of non-invasive medical devices for pain
management, stroke rehabilitation, cardiac monitoring and
neurological diagnostics today announced that Thomas Sandgaard, Chief Executive Officer of
Zynex will present at the Raymond James Life Sciences and MedTech
Conference. Mr. Sandgaard will also meet with members of the
investment community during one-on-one meetings at the
conference.
Event:
|
Raymond James Life
Sciences and MedTech Conference
|
Date:
|
Tuesday, June 18,
2019
|
Presentation
Time:
|
11:30 AM – 12:00 PM
ET
|
Location:
|
Lotte New York
Palace
New York, New York
|
The presentation will be webcast live on the Investors section
of the Company's website at
http://zynexmed.investorroom.com/presentations-events-and-webcasts.
Interested parties can also access an archived version of the
presentation on the Company's website for approximately 90 days
after the event concludes.
ABOUT ZYNEX
Zynex, founded in 1996, markets and sells its own design of
electrotherapy medical devices used for pain management and
rehabilitation; and the company's proprietary NeuroMove device
designed to help recovery of stroke and spinal cord injury
patients. Zynex is also developing a new blood volume monitor for
use in hospitals and surgery centers. For additional
information, please visit: Zynex.com.
ZYNEX INVESTOR RELATIONS CONTACT:
Amato and Partners, LLC
100 Park Avenue, 16th Floor
New York, NY 10017
(212) 430-0360
admin@amatoandpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/zynex-to-present-at-raymond-james-life-sciences-and-medtech-conference-300865817.html
SOURCE Zynex, Inc.